Sponsor Pipeline

Kinaset Therapeutics Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT07532265
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients…		 Recruitment opened
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07532265 A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients… Severe Asthma Recruiting
Disease Areas
Asthma (1)
Get alerts when Kinaset Therapeutics Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free